Press "Enter" to skip to content

New patent expiration for Chiesi drug BETHKIS

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Chiesi drug BETHKIS

Annual Drug Patent Expirations for BETHKIS
Annual Drug Patent Expirations for BETHKIS

Bethkis is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for BETHKIS.

This drug has thirty-four patent family members in twenty-six countries.

The generic ingredient in BETHKIS is tobramycin. Two suppliers are listed for this compound. Additional details are available on the tobramycin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Chiesi drug BETHKIS
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions